IDA (IDA)

$7.9B
Market Cap
24.2
P/E Ratio
0.55
Beta
2.48%
Dividend Yield
Piotroski 6/9Altman Z 1.3 DistressBeneish M -2.80 CleanROIC−WACC -2.9%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9, Altman Z 1.3.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The company exhibits a distinct capital allocation profile where high profitability is achieved through operational leverage rather than asset efficiency or financial risk. A DuPont decomposition reveals that the 9.0% ROE is primarily driven by an expansive net margin of 17.8%, while low asset turnover at 0.18x and modest equity multipliers limit growth potential relative to peers. Despite a negative revenue trajectory of -0.8% YoY, quality indicators remain robust; the Piotroski F-Score of 6/9 suggests solid financial health with no distress signals, reinforced by a Beneish M-Score of -2.80 that points toward low earnings manipulation risk. This combination indicates an entity capable of generating strong returns on equity despite stagnant top-line growth and suboptimal capital efficiency compared to high-growth peers.

Valuation metrics present a divergence between current pricing and historical norms, with the stock trading at 24.2x forward earnings. While this multiple exceeds typical value benchmarks for firms exhibiting negative revenue momentum, it aligns more closely with quality names that sustain double-digit margins. The market appears to be pricing in an expectation of margin expansion or eventual top-line stabilization, as current cash flows do not fully justify the premium without assuming significant future growth acceleration. A discounted cash flow framework would likely challenge this multiple unless implied long-term growth rates significantly outpace industry averages to offset the recent contraction in sales volume.

Risk assessment is further complicated by insider activity, which shows $539,000 of net selling over the past 90 days. While the strong fundamental scores mitigate concerns regarding financial engineering or imminent distress, this capital outflow from management suggests a lack of confidence at current price levels or potential hedging against anticipated volatility. Investors must weigh whether the high margin durability and clean governance signals outweigh the insider disposition and the inherent risk of continued revenue stagnation when determining fair value relative to these specific data points.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
1.3
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.80
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

19.8%
Gross Margin
17.8%
Net Margin
4.0%
ROIC
7.0%
WACC
ROIC − WACC Spread: -2.9%— Negative spread.
-0.8%
Revenue Growth (YoY)
+11.9%
Earnings Growth (YoY)
-577.5M
Free Cash Flow

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

17.8%
Net Profit Margin
NI ÷ Revenue
×
0.18x
Asset Turnover
Revenue ÷ Assets
×
2.86x
Equity Multiplier
Assets ÷ Equity
=
9.0%
Return on Equity
✅ ROE driven primarily by strong profit margins — a sign of pricing power.

Balance Sheet Health

1.86x
Debt / Equity
0.93x
Current Ratio
2.8x
Interest Coverage
4.2x
Net Debt / EBITDA
-5.26%
FCF Yield
737.0M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
$-539,000
Net Selling
0
Buy Transactions
3
Sale Transactions
2026-03-03TATUM TIMOTHY ESold 2/8 qtrsSale$210,772
2026-02-27JOHNSON DENNIS LGrant1,007 shares
2026-02-27ELG ANNETTE GGrant1,007 shares
2026-02-27KENNEDY MICHAEL JOSEPHGrant1,007 shares
2026-02-27JORGENSEN NATE RGrant1,007 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $1.05
Act: $1.10
+5.0%
Q3
✗ Miss
Est: $1.78
Act: $1.76
-1.0%
Q2
✓ Beat
Est: $2.26
Act: $2.26
+0.1%
Q1
✓ Beat
Est: $0.73
Act: $0.78
+6.6%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

20.7
Forward P/E
PEG Ratio
2.20
Price/Book
459796
Avg Volume
$145.94
52W High
$108.15
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$761M
Tracked Passive Exposure
8
ETFs Holding IDA
0.12%
Avg Weight in ETFs
$629B
Total ETF AUM

When investors buy or sell ETFs like DVY or VPU, the fund manager is mechanically forced to buy or sell IDA shares regardless of IDA's individual fundamentals. We estimate $761M of passive capital is structurally linked to IDA through 8 tracked ETFs. Passive flows have a limited but growing influence on IDA's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in IDA to visualize passive redemption contagion across ETFs and collateral stocks.

IDA Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
IDAEpicenterVBETFVIGETFVYMETFNEEHigh RiskSOHigh RiskDUKHigh RiskCEGMed RiskAEPHigh Risk
IDA Price Drop (%)0

If IDA (IDA) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies NextEra Energy Inc. (NEE) as the most exposed collateral stock, sharing 1 ETFs with IDA. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 17 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

IDA Ownership Dynamics

Ticker
IDA

Float lock-up computed from 17 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

IDA Capital Efficiency

How efficiently does IDA convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$-577,489,000
EBITDA
$737M
FCF Conversion
-78%
Reinvestment Rate
178%
-78% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
4.0%
ROIC − WACC Spread
-2.9%

IDA converts -78% of its EBITDA into free cash flow, negative FCF conversion — the company is consuming cash faster than it generates EBITDA, which is unsustainable long-term. The 178% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-2.9%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-138$143.72$1,149.76
2026-05-12379$145.41$55,110.39
2026-05-05194$146.61$28,442.34
2026-05-011,559$147.74$230,326.66
2026-04-2917,572$145.62$2.6M
2026-04-27308$146.06$44,986.48
2026-04-244,515$148.82$671,922.3
2026-04-23332$143.51$47,645.32
2026-04-16397$146.51$58,164.47
2026-04-091,100$146.31$160,941
2026-03-2723$139.58$3,210.34
2026-03-2629,894$138.56$4.1M
2026-03-178,423$142.68$1.2M
2026-03-1028$142.59$3,992.52
2026-03-095,449$142.64$777,245.36
2026-03-04593$143.69$85,208.17
2026-03-025,917$143.97$851,870.49
2026-02-25226$143.26$32,376.76
2026-02-2420,946$143.45$3.0M
2026-02-1930,141$141.74$4.3M
2026-02-1311,965$141.39$1.7M
2026-02-0585$134.03$11,392.55
2026-02-029,362$132.79$1.2M
2026-01-303,647$132.23$482,242.81
2026-01-22327$134.00$43,818
2026-01-202,092$134.61$281,604.12
2026-01-159,985$132.22$1.3M
2025-12-311$127.44$127.44
2025-11-262,787$129.53$361,000.11
2025-11-21657$126.77$83,287.89

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare IDA to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.